Mary Katherine Blazar – Trademark Portfolio

Entity Type: 01

Mary Katherine Blazar holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ANIMOSA and GO WITH YOUR FLOW. The owner is based in Eugene, OR.

Post Office Box 5137

Eugene, OR 97405

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Mary Katherine Blazar's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Mary Katherine Blazar have?

Mary Katherine Blazar has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Mary Katherine Blazar file in?

Mary Katherine Blazar files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Mary Katherine Blazar's most well-known trademarks?

Mary Katherine Blazar's registered trademark portfolio includes well-known marks such as ANIMOSA and GO WITH YOUR FLOW. These are among 2 currently registered trademarks in the portfolio.

What is Mary Katherine Blazar's trademark registration success rate?

Mary Katherine Blazar has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.